SCA Pharma

SCA Pharma is a leading player in the FDA 503B outsourcing industry, specializing in providing top-tier sterile admixtures and pre-filled syringes to hospitals and health systems nationally. With a strong emphasis on customer and patient satisfaction, SCA Pharma prides itself on its unwavering commitment to quality and personalized service. The company operates from two facilities, boasting a total of over 100,000 square feet of sterile compounding laboratory and manufacturing space, all of which meet or exceed FDA cGMP manufacturing guidelines. Established in 2011, SCA Pharma now employs more than 500 individuals across both locations, in addition to a team of sales representatives nationwide. In January 2021, SCA Pharma secured a Private Equity Round investment led by Excellere Partners, signifying a vote of confidence in the company's vision and operations. As the most customer and patient-centric service provider in the 503B industry, SCA Pharma continues to demonstrate its potential for growth and impact in the Health Care and Pharmaceutical sectors.